SCHEMBL10593192

SCHEMBL10593192

CC1=CC2=C(Sc3ccccc3N2)C(Br)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ GAA P10253 8/20 0.41
▸ MAPT P10636 8/20 0.41
▸ MEN1 O00255 7/20 0.41
▸ KMT2A Q03164 7/20 0.41
▸ NOX1 Q9Y5S8 6/20 0.41
▸ TDP1 Q9NUW8 4/20 0.41
▸ SNCA P37840 3/20 0.41
▸ ALOX15 P16050 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10593347 0.83 L3MBTL1 (0.43) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL9813210 0.70 MAPT (0.41) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL16061814 0.69 L3MBTL1 (0.43) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL10590538 0.69 MEN1 (0.40) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL10591953 0.69 EPHX2 (0.41) GAAMAPTMEN1KMT2ANOX1
SCHEMBL2987616 0.68 SNCA (0.50) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL1201818 0.68 L3MBTL1 (0.45) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL9813116 0.67 NOX1 (0.41) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL9813103 0.66 GAA (0.39) L3MBTL1GAAMAPTMEN1KMT2A
SCHEMBL10591310 0.66 NOX1 (0.40) L3MBTL1GAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115394-B1 PHENOTHIAZONE DERIVATIVES AND ANALOGS MERCK FROSST CANADA INC. (CA) 1989-06-28 — — EP disclosed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
EP-0115394-A2 Phenothiazone derivatives and analogs MERCK FROSST CANADA INC. (CA) 1984-08-08 — — EP disclosed
Send feedback